However, only 20% of patients with ischemic stroke receive tPA treatment because of its limited therapeutic window of 4.5 h and its severe side effects, including an increased risk of symptomatic intracerebral hemorrhage (Deng et al., 2019). Here, PLAT is linked to ischemic stroke.